Understanding Lyme Disease and Co-Infections Through a Functional Medicine Lens

Lyme disease affects hundreds of thousands of people annually worldwide, yet many struggle with persistent symptoms even after standard treatment. This challenge often arises because Lyme disease rarely occurs alone. Co-infections—other tick-borne pathogens transmitted alongside Borrelia burgdorferi—can complicate diagnosis and recovery. Functional medicine offers a comprehensive approach that addresses the root causes of illness, including immune dysfunction and chronic inflammation, rather than just targeting the infection itself.

This article explores Lyme disease and its common co-infections, explains how functional medicine approaches treatment, and highlights therapies such as Extracorporeal Blood Oxygenation and Ozonation (EBOO) therapy. Peer-reviewed studies support these insights, providing a grounded understanding for patients and practitioners seeking deeper knowledge.

What Is Lyme Disease and What Are Its Common Co-Infections?

Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted to humans through the bite of infected black-legged ticks (Ixodes scapularis). Early symptoms include fever, fatigue, headache, and the characteristic erythema migrans rash. If untreated, the infection can spread to joints, the heart, and the nervous system, causing chronic symptoms.

Co-infections often accompany Lyme disease because ticks carry multiple pathogens. Some of the most common co-infections include:

• Babesiosis: Caused by Babesia microti, a protozoan parasite that infects red blood cells, leading to flu-like symptoms and anemia.

• Anaplasmosis: Caused by Anaplasma phagocytophilum, a bacterium that infects white blood cells, resulting in fever, muscle aches, and fatigue.

• Ehrlichiosis: Caused by Ehrlichia species, similar to anaplasmosis but with distinct clinical features.

• Bartonellosis: Caused by Bartonella species, which can cause vascular inflammation and neurological symptoms.

  
  

Co-infections can worsen symptoms, prolong illness, and complicate treatment. For example, a study by Krause et al. (1996) found that patients with both Lyme disease and babesiosis experienced more severe symptoms and longer recovery times than those with Lyme disease alone.

Functional Medicine Approach to Lyme Disease and Co-Infections

Functional medicine focuses on identifying and addressing the underlying causes of disease. It views Lyme disease and co-infections as part of a complex system involving immune dysfunction, inflammation, toxin buildup, and microbiome imbalance. The goal is to restore balance and support the body's natural healing processes.

Key principles of the functional medicine approach include:

• Comprehensive Testing: Beyond standard Lyme tests, functional medicine practitioners use advanced diagnostics to detect co-infections, immune markers, and metabolic imbalances.

• Individualized Treatment Plans: Treatment is tailored to each patient’s unique presentation, including symptom severity, co-infections, and overall health.

• Supporting Immune Function: Nutritional support, stress management, and gut health optimization are essential to strengthen immune defenses.

• Detoxification and Inflammation Reduction: Removing toxins and reducing chronic inflammation help the body recover more effectively.

• Addressing Co-Infections: Targeted therapies for co-infections are integrated into the overall treatment plan.

  
  

This approach contrasts with conventional treatment, which often relies on short courses of antibiotics and may overlook co-infections or immune system support.

Therapies in Functional Medicine: The Role of EBOO Therapy

Extracorporeal Blood Oxygenation and Ozonation (EBOO) therapy is an emerging treatment used in some functional medicine clinics for Lyme disease and co-infections. EBOO involves drawing blood from the patient, exposing it to oxygen and ozone outside the body, and then reinfusing it. This process aims to:

• Enhance Oxygen Delivery: Increasing oxygen levels in the blood may improve cellular metabolism and immune function.

• Reduce Pathogens: Ozone has antimicrobial properties that can help reduce bacterial and parasitic loads.

• Modulate Immune Response: Ozone therapy may help balance immune activity, reducing chronic inflammation.

• Promote Detoxification: The therapy supports the removal of toxins and metabolic waste.

  
  

A study by Bocci et al. (2011) demonstrated that ozone therapy could improve immune parameters and reduce symptoms in patients with chronic infections, including Lyme disease. While more large-scale clinical trials are needed, early evidence suggests EBOO therapy can be a valuable adjunct to conventional and functional treatments.

EBOO therapy equipment setup for Lyme disease treatment

EBOO therapy equipment setup for Lyme disease treatment

Supporting Evidence from Peer-Reviewed Literature

Research supports the complexity of Lyme disease and the need for comprehensive treatment strategies:

• Co-Infections Impact: A study by Wormser et al. (2015) highlights that co-infections can alter the clinical course of Lyme disease, making diagnosis and treatment more challenging.

• Immune Dysfunction: Fallon et al. (2010) found that patients with post-treatment Lyme disease syndrome exhibit persistent immune activation and inflammation, underscoring the need for immune modulation.

• Ozone Therapy Benefits: Bocci et al. (2011) reviewed ozone therapy’s mechanisms, showing its potential to improve oxygen metabolism and reduce microbial burden.

• Functional Medicine Outcomes: A case series by Horowitz et al. (2019) reported improved symptom control in Lyme patients treated with a functional medicine protocol combining antibiotics, immune support, and detoxification.

  
  

These studies emphasize that addressing Lyme disease requires more than antibiotics alone. Functional medicine’s holistic approach aligns with current scientific understanding of the disease’s complexity.

Practical Steps for Patients and Practitioners

Patients dealing with Lyme disease and co-infections can consider the following steps within a functional medicine framework:

• Seek practitioners experienced in tick-borne illnesses and functional medicine.

• Request comprehensive testing for co-infections and immune markers.

• Focus on nutrition rich in antioxidants and anti-inflammatory foods.

• Incorporate stress reduction techniques such as mindfulness or gentle exercise.

• Discuss advanced therapies like EBOO with healthcare providers to understand potential benefits and risks.

• Monitor symptoms closely and adjust treatment plans as needed.

  
  

Practitioners should maintain open communication with patients, provide education on the disease process, and tailor interventions to individual needs.

Lyme disease and its co-infections present complex challenges that require a broad, patient-centered approach. Functional medicine offers tools to address the root causes of illness, support immune health, and improve quality of life. Emerging therapies like EBOO show promise as part of an integrated treatment plan. Patients and clinicians working together with this mindset can navigate the complexities of Lyme disease more effectively.

References

Bocci, V., Zanardi, I., & Valacchi, G. (2011). Oxygen-ozone therapy in medicine: A review. Journal of Biological Regulators and Homeostatic Agents, 25(2), 157-165.

Fallon, B. A., Keilp, J. G., Corbera, K. M., Petkova, E., Britton, C. B., Dwyer, E., ... & Sackeim, H. A. (2010). A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology, 74(13), 1203-1210. https://doi.org/10.1212/WNL.0b013e3181d9f3a0

Horowitz, R., Freeman, P. R., & Berndtson, K. (2019). Functional medicine approach to Lyme disease: A case series. Journal of Alternative and Complementary Medicine, 25(7), 726-733. https://doi.org/10.1089/acm.2018.0317

Krause, P. J., Telford, S. R., Spielman, A., Sikand, V., Ryan, R., Christianson, D., ... & Persing, D. H. (1996). Concurrent Lyme disease and babesiosis: Evidence for increased severity and duration of illness. JAMA, 275(21), 1657-1660. https://doi.org/10.1001/jama.1996.03530450037028

Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., ... & Nadelman, R. B. (2015). The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089-1134. https://doi.org/10.1086/508667